Menu
Synergy in Action

Utilizing Artificial Intelligence and Machine Learning for CNS Clinical Trials

Chairs: Larry Alphs, MD, PhD; Adam Butler

Working Group Deliverable:
Comment on FDA Proposed Regulatory Framework for Modifications to Artificial Intelligence-Machine-Learning Based Software as a Medical Device (SaMD)
(June 2019)

Inaugural Working Group session  2019 Autumn Conference includes Joint Day with ECNP, 7 September, 2019, Copenhagen, Denmark

RETURN TO WORKING GROUP PAGE